S&P 500   3,360.47 (+0.27%)
DOW   27,791.44 (+1.30%)
QQQ   270.31 (-0.43%)
AAPL   450.54 (+1.37%)
MSFT   208.27 (-1.98%)
FB   262.71 (-2.13%)
GOOGL   1,495.93 (-0.16%)
AMZN   3,148.16 (-0.61%)
NVDA   446.65 (-0.30%)
CGC   17.78 (+6.92%)
BABA   248.13 (-1.57%)
TSLA   1,413.60 (-2.69%)
GE   6.67 (+4.22%)
MU   49.08 (+0.68%)
AMD   82.24 (-3.08%)
T   30.20 (+0.60%)
F   7.09 (+3.35%)
ACB   10.23 (-0.39%)
GILD   68.55 (-1.15%)
NFLX   483.38 (-2.29%)
DIS   129.05 (-0.68%)
BAC   26.56 (+1.72%)
BA   179.41 (+5.52%)
S&P 500   3,360.47 (+0.27%)
DOW   27,791.44 (+1.30%)
QQQ   270.31 (-0.43%)
AAPL   450.54 (+1.37%)
MSFT   208.27 (-1.98%)
FB   262.71 (-2.13%)
GOOGL   1,495.93 (-0.16%)
AMZN   3,148.16 (-0.61%)
NVDA   446.65 (-0.30%)
CGC   17.78 (+6.92%)
BABA   248.13 (-1.57%)
TSLA   1,413.60 (-2.69%)
GE   6.67 (+4.22%)
MU   49.08 (+0.68%)
AMD   82.24 (-3.08%)
T   30.20 (+0.60%)
F   7.09 (+3.35%)
ACB   10.23 (-0.39%)
GILD   68.55 (-1.15%)
NFLX   483.38 (-2.29%)
DIS   129.05 (-0.68%)
BAC   26.56 (+1.72%)
BA   179.41 (+5.52%)
S&P 500   3,360.47 (+0.27%)
DOW   27,791.44 (+1.30%)
QQQ   270.31 (-0.43%)
AAPL   450.54 (+1.37%)
MSFT   208.27 (-1.98%)
FB   262.71 (-2.13%)
GOOGL   1,495.93 (-0.16%)
AMZN   3,148.16 (-0.61%)
NVDA   446.65 (-0.30%)
CGC   17.78 (+6.92%)
BABA   248.13 (-1.57%)
TSLA   1,413.60 (-2.69%)
GE   6.67 (+4.22%)
MU   49.08 (+0.68%)
AMD   82.24 (-3.08%)
T   30.20 (+0.60%)
F   7.09 (+3.35%)
ACB   10.23 (-0.39%)
GILD   68.55 (-1.15%)
NFLX   483.38 (-2.29%)
DIS   129.05 (-0.68%)
BAC   26.56 (+1.72%)
BA   179.41 (+5.52%)
S&P 500   3,360.47 (+0.27%)
DOW   27,791.44 (+1.30%)
QQQ   270.31 (-0.43%)
AAPL   450.54 (+1.37%)
MSFT   208.27 (-1.98%)
FB   262.71 (-2.13%)
GOOGL   1,495.93 (-0.16%)
AMZN   3,148.16 (-0.61%)
NVDA   446.65 (-0.30%)
CGC   17.78 (+6.92%)
BABA   248.13 (-1.57%)
TSLA   1,413.60 (-2.69%)
GE   6.67 (+4.22%)
MU   49.08 (+0.68%)
AMD   82.24 (-3.08%)
T   30.20 (+0.60%)
F   7.09 (+3.35%)
ACB   10.23 (-0.39%)
GILD   68.55 (-1.15%)
NFLX   483.38 (-2.29%)
DIS   129.05 (-0.68%)
BAC   26.56 (+1.72%)
BA   179.41 (+5.52%)
Log in

NASDAQ:CRNXCrinetics Pharmaceuticals Earnings Date, Estimates & History

$17.02
+0.88 (+5.45 %)
(As of 08/10/2020 04:00 PM ET)
Add
Compare
Today's Range
$15.95
Now: $17.02
$17.15
50-Day Range
$13.88
MA: $16.39
$23.23
52-Week Range
$10.63
Now: $17.02
$26.67
Volume106,830 shs
Average Volume153,801 shs
Market Capitalization$559.04 million
P/E RatioN/A
Dividend YieldN/A
Beta1.12

Earnings

Crinetics Pharmaceuticals (NASDAQ:CRNX) Earnings Information

Crinetics Pharmaceuticals last posted its earnings results on August 7th, 2020. The reported ($0.53) earnings per share for the quarter, beating the consensus estimate of ($0.55) by $0.02. Crinetics Pharmaceuticals has generated ($2.09) earnings per share over the last year. Crinetics Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 10th, 2020 based off prior year's report dates.

Crinetics Pharmaceuticals Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Crinetics Pharmaceuticals (NASDAQ:CRNX) Earnings Estimates

2020 EPS Consensus Estimate: ($2.47)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20202($0.60)($0.60)($0.60)
Q2 20202($0.65)($0.50)($0.58)
Q3 20202($0.75)($0.54)($0.65)
Q4 20202($0.80)($0.50)($0.65)
Q1 20211($0.75)($0.75)($0.75)
Q2 20211($0.85)($0.85)($0.85)
Q3 20211($0.90)($0.90)($0.90)

Crinetics Pharmaceuticals (NASDAQ CRNX) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
11/10/2020
(Estimated)
       
8/7/20206/30/2020($0.55)($0.53)($0.53)N/A
5/8/20203/31/2020($0.63)($0.71)($0.71)$0.07 millionN/A
3/9/202012/31/2019($0.68)($0.60)($0.60)$0.30 million$0.32 millionN/A
11/12/2019Q3 2019($0.5680)($0.60)($0.60)$0.33 million$0.51 millionN/A
8/13/2019Q2 2019($0.4560)($0.51)($0.51)$0.33 millionN/A
5/13/2019Q1($0.41)($0.37)($0.37)$0.25 million$0.37 millionN/A
3/13/2019Q4($0.4120)($0.35)($0.35)$0.32 million$0.78 millionN/A
11/13/2018Q3 2018($0.3430)($0.38)($0.38)$0.28 million$0.55 millionN/A
8/30/2018Q2 2018($0.2870)($2.41)($2.41)$0.09 million$0.66 millionN/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 8/10/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.